VEGFA and neoplasm: The above-mentioned concludes that, Conbercept is a safe and effective anti-vascular endothelial growth factor (anti-VEGF) drug which could exert potent anti-angiogenic and anti-tumor effects due to the inhibitory effects to VEGF in vitro and vivo, and proved to be a promising option for the treatment of CNV [3, 7].